Serum brain-derived neurotrophic factor response to maximal exercise in coronary artery disease and chronic heart failure

Serum brain-derived neurotrophic factor response to maximal exercise in coronary artery disease and chronic heart failure. Download PDF Abstract Brain-derived neurotrophic factor (BDNF) has emerged as a prognostic biomarker in coronary artery disease (CAD) and chronic heart failure (CHF). While exercise is known to acutely elevate BDNF in healthy populations, evidence in CAD and CHF remains limited.

The aims of the study were: to compare resting serum BDNF concentrations between patients with CAD, CHF, and healthy controls; to determine the acute effect of a maximal cardiopulmonary exercise test (CPET) on serum BDNF; and to explore potential moderating factors (i.e., sex, age, body mass index, lactate). Fifteen patients with CHF, 14 with CAD, and 14 age-matched healthy individuals (all male or postmenopausal females, 40–75 years) underwent a symptom-limited CPET with blood sampling pre- and post-exercise. Repeated-measures ANOVA models and Pearson correlations were used to conduct data analyses.

Resting serum BDNF levels were significantly lower in CAD patients compared to healthy controls (–11.38 ng·ml⁻¹; 95% CI = − 18.65, − 4.10). No statistically significant differences were found between the other groups ( p >.050). Maximal exercise induced a significant increase in serum BDNF (5.99 ng·ml⁻¹; 95% CI = 2.44, 9.54), with no significant differences between groups ( p =.987).

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with qualified healthcare professionals for medical decisions and treatment options.